News and Announcements
EDITORIAL
Circadian rhythms in Alzheimer’s disease: A molecular clock worth watching
Show Less
1 Department of Neurology, Annapurna Neurological Institute and Allied Sciences, Kathmandu,
Nepal
2 International Medical School and Postgraduate Centre, Management and Science University, Shah Alam, Selangor,
Malaysia
GPD, 025160031 https://doi.org/10.36922/GPD025160031
Received: 14 April 2025 | Accepted: 16 April 2025 | Published online: 19 May 2025
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
The author declares no conflict of interest.
References
- Hippius H, Neundorfer G. The discovery of Alzheimer’s disease. Dialogues Clin Neurosci. 2003;5(1):101-108. doi: 10.31887/DCNS.2003.5.1/hhippius
- Korczyn AD, Grinberg LT. Is Alzheimer disease a disease? Nat Rev Neurol. 2024;20(4):245-251. doi: 10.1038/s41582-024-00940-4
- Hoyt KR, Obrietan K. Circadian clocks, cognition, and Alzheimer’s disease: Synaptic mechanisms, signaling effectors, and chronotherapeutics. Mol Neurodegener. 2022;17(1):35. doi: 10.1186/s13024-022-00537-9
- Gibson M. A systematic review of the relationship between night shift work and oxidative stress. Chronobiol Int. 2022;39(2):285-298. doi: 10.1080/07420528.2021.1989446
- Gonzales PNG, Villaraza SG, Rosa JCD. The association between sleep and Alzheimer’s disease: A systematic review. Dement Neuropsychol. 2024;18:e20230049. doi: 10.1590/1980-5764-DN-2023-0049
- Morrone CD, Raghuraman R, Hussaini SA, Yu WH. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease. Mol Neurodegener. 2023;18(1):27. doi: 10.1186/s13024-023-00617-4
- Son G, Neylan TC, Grinberg LT. Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: Evidence from human studies and animal models. Mol Neurodegener. 2024;19(1):4. doi: 10.1186/s13024-023-00695-4
- Mueed Z, Rai PK, Kamal MA, Poddar NK. Decoding the inter-relationship between sleep disorders and Alzheimer’s disease pathogenesis. CNS Neurol Disord Drug Targets. 2021;20(8):723-735. doi: 10.2174/1871527319666200903161249
- Carpi M, Mercuri NB, Liguori C. Orexin receptor antagonists for the prevention and treatment of Alzheimer’s disease and associated sleep disorders. Drugs. 2024;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3
- Currenti W, Godos J, Castellano S, et al. Time restricted feeding and mental health: A review of possible mechanisms on affective and cognitive disorders. Int J Food Sci Nutr. 2021;72(6):723-733. doi: 10.1080/09637486.2020.1866504
- Mehramiz M, Porter T, O’Brien EK, Rainey-Smith SR, Laws SM. A potential role for sirtuin-1 in Alzheimer’s disease: Reviewing the biological and environmental evidence. J Alzheimers Dis Rep. 2023;7(1):823-843. doi: 10.3233/ADR-220088
- Sharma A, Lee S, Kim H, Yoon H, Ha S, Kang SU. Molecular Crosstalk Between Circadian Rhythmicity and the Development of Neurodegenerative Disorders. Front Neurosci. 2020;14:844. doi: 10.3389/fnins.2020.00844